EUVIMEDEUVIMED entdecken
Open Access

Repositioning of aripiprazole, an anti‑psychotic drug, to sensitize the chemotherapy of pancreatic cancer

Ye Jin Cho, Beom Seok Han, Soyeon Ko, Min Seok Park, Yun Ji Lee, Sang Eun Kim, Pureunchowon Lee, Han Gyeol Go, Shinyoung Park, Hyunho Lee, Sohee Kim, Eun-Ran Park und 2 weitere

International Journal of Molecular Medicine · 2024

DOI: 10.3892/ijmm.2024.5458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2024. Verfasst von Ye Jin Cho und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Medicine and Program in Biomedical Science and Engineering, Inha University, Incheon 22332, Republic of…. Hauptthemen laut MEDLINE: Aripiprazole, Pancreatic Neoplasms, Drug Repositioning, Cisplatin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited therapeutic options. Cisplatin is a primary chemotherapeutic agent utilized in combination with other drugs or radiotherapy for PDAC treatment. However, the severe side effects of cisplatin often necessitate discontinuation of therapy and drug resistance in tumor cells poses significant clinical challenges. Therefore, the development of effective therapeutic strategies is imperative. The present study investigated whether repositioning of the antipsychotic drug aripiprazole could sensitize the anticancer activity of cisplatin in pancreatic cancer at doses calculated by the combination index. The findings indicated that aripiprazole combined with cisplatin to suppress pancreatic cancer cell growth. Notably, the combination notably increased the expression of apoptosis markers, including cleaved caspase‑3, compared with cisplatin alone. Additionally, this combination effectively decreased XIAP and MCL‑1 expression via mitochondrial membrane potential change as revealed by JC‑1 assay, thereby inducing apoptosis. Furthermore, in fluid shear stress assay, the combination of aripiprazole and cisplatin notably inhibited cell adhesion and tumor spheroid formation. Mechanistically, phospho‑kinase array profiles showed that the enhanced anticancer efficacy of the combination treatment could be attributed to the inhibition of STAT3 signaling, which led to a significant reduction in tumor growth in a pancreatic cancer animal model. The results showed that the repositioning of aripiprazole inhibits cancer cell growth by blocking the STAT3 signaling pathway and effectively enhancing cisplatin‑induced apoptosis, thereby suggesting that the combination of aripiprazole and cisplatin may be a potent chemotherapeutic strategy for the treatment of pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AripiprazolePancreatic NeoplasmsDrug RepositioningCisplatinApoptosisHumansAnimalsCell Line, TumorMiceAntipsychotic AgentsCell ProliferationSTAT3 Transcription FactorXenograft Model Antitumor AssaysMice, NudeDrug SynergismAntineoplastic AgentsSignal TransductionCarcinoma, Pancreatic DuctalCell Adhesion

Stichwörter der Autor:innen

STAT3apoptosiscisplatindrug repositioningpancreatic cancertumor

Substanzen

AripiprazoleCisplatinAntipsychotic AgentsSTAT3 Transcription FactorAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, College of Medicine and Program in Biomedical Science and Engineering, Inha University, Incheon 22332, Republic of Korea.
  • Anti‑cancer Strategy Research Institute, VSPharmTech, Inc., Seoul Technopark, Seoul 01811, Republic of Korea.

Zitieren

APA

Cho, Y. J., Han, B. S., Ko, S., Park, M. S., Lee, Y. J., Kim, S. E., Lee, P., Go, H. G., Park, S., Lee, H., Kim, S., Park, E. R., Jung, K. H., & Hong, S. S. (2024). Repositioning of aripiprazole, an anti‑psychotic drug, to sensitize the chemotherapy of pancreatic cancer. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2024.5458

Vancouver

Cho YJ, Han BS, Ko S, Park MS, Lee YJ, Kim SE, et al. Repositioning of aripiprazole, an anti‑psychotic drug, to sensitize the chemotherapy of pancreatic cancer. International Journal of Molecular Medicine. 2024. doi:10.3892/ijmm.2024.5458

BibTeX
@article{Cho2024,
  author = {Cho, Ye Jin and Han, Beom Seok and Ko, Soyeon and Park, Min Seok and Lee, Yun Ji and Kim, Sang Eun and Lee, Pureunchowon and Go, Han Gyeol and Park, Shinyoung and Lee, Hyunho and Kim, Sohee and Park, Eun-Ran and Jung, Kyung Hee and Hong, Soon-Sun},
  title = {Repositioning of aripiprazole, an anti‑psychotic drug, to sensitize the chemotherapy of pancreatic cancer},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  doi = {10.3892/ijmm.2024.5458}
}
Kostenlos starten →